3D Systems Receives FDA Clearance For NextDent Base
Portfolio Pulse from Benzinga Newsdesk
3D Systems (NYSE:DDD) has received FDA 510(k) clearance for its NextDent Base material for 3D printing denture bases. This third-generation material offers high break resistance, accurate printing, and repeatable results. It is part of 3D Systems' portfolio of 30 unique NextDent resins, the largest from any dental 3D printing material supplier. The material has received positive feedback from dental professionals and is expected to contribute to the growing 3D-printed denture market, which is anticipated to reach over $2 billion by 2028. NextDent Base is available in four colors and is part of 3D Systems' digital dental workflow, which aims to improve speed, productivity, efficiency, and patient experience.
November 15, 2023 | 1:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
3D Systems' NextDent Base has received FDA clearance, indicating a positive regulatory milestone and potential revenue growth from the dental 3D printing market.
The FDA clearance is a critical regulatory step that allows 3D Systems to market and sell its NextDent Base material in the U.S. This approval, along with positive market feedback, positions the company to capitalize on the expanding 3D-printed denture market. The news is likely to be viewed positively by investors, potentially leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100